Strong week for Precigen (NASDAQ:PGEN) shareholders doesn't alleviate pain of five-year loss
We're definitely into long term investing, but some companies are simply bad investments over any time frame. It hits...
Source: yahoo.com
Page 6 - Precigen News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Precigen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Precigen Today - Breaking & Trending Today
Precigen Announces Positive Phase 1 Data for PRGN-3005 Autologous UltraCAR-T® Cells Manufactured Overnight for Infusion Next Day to Advanced Stage Platinum Resistant Ovarian Cancer Patients
– PRGN-3005 was well-tolerated with no dose limiting toxicities, no CRS greater than Grade 2, and no neurotoxicity – – PRGN-3005 cells demonstrated expansion...
Source: prnewswire.com
Precigen Gets FDA Clearance to Start Phase 2 Study of AdenoVerse Immunotherapy
By Chris Wack Precigen said Wednesday the U.S. Food and Drug Administration has cleared the Investigational New Drug application to begin a Phase 2 study of its first-in-class PRGN-2009... | May 31, 2023
Source: marketscreener.com
Precigen (NASDAQ:PGEN) Earns Neutral Rating from Analysts at JPMorgan Chase & Co.
JPMorgan Chase & Co. started coverage on shares of Precigen (NASDAQ:PGEN – Get Rating) in a report released on Tuesday morning, The Fly reports. The brokerage issued a neutral rating on the biotechnology company’s stock. PGEN has been the subject of a number of other research reports. HC Wainwright reaffirmed a buy rating and issued […]
Source: themarketsdaily.com
Precigen (NASDAQ:PGEN) Coverage Initiated at JPMorgan Chase & Co.
JPMorgan Chase & Co. started coverage on shares of Precigen (NASDAQ:PGEN – Get Rating) in a research report sent to investors on Tuesday morning, The Fly reports. The brokerage issued a neutral rating on the biotechnology company’s stock. A number of other equities analysts also recently weighed in on the stock. StockNews.com started coverage on […]
Source: modernreaders.com